REMEDIAL III Clinical study of RenalGuard Therapy shows positive results
The REMEDIAL III Clinical study demonstrated that RenalGuard Therapy is more effective in preventing the composite of CI-AKI…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Oct 19
The REMEDIAL III Clinical study demonstrated that RenalGuard Therapy is more effective in preventing the composite of CI-AKI…
04 Oct 19
InMode develops, manufactures, and markets devices harnessing novel radio-frequency technology
03 Oct 19
The SeeFactorCT3 computed tomography platform uses dynamic flat panel sensor technology that acquires sequences of the head
03 Oct 19
ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in…
01 Oct 19
Inscripta introduced benchtop platform for digital genome engineering, featuring software, consumables, an instrument, and assays for precisely engineering…
01 Oct 19
The PROMISE Clinical Study has been designed to evaluate the safety and efficacy of the Eversense CGM System…
30 Sep 19
Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients and vulnerable plaques that are at…
27 Sep 19
AI-Rad Companion Chest CT differentiates among various structures in that region – including the lungs, heart, and aorta
26 Sep 19
The Loop-X robotic architecture introduces a new standard in flexibility, adding additional degrees of freedom to any surgical…
25 Sep 19
The target yield increase is accomplished by combining the ability to process a wide range of sample volumes…